Unsubscribe

You will not receive any more emails from HRTechdepot.

Advanced Rehabilitation, LLC Expands iKNOT Curriculum to Address Complex Regional Pain Syndrome & Chronic Upper Extremity Problems

2026-06-23T10:03:43Z

CHARLOTTE, N.C., June 23, 2026 (GLOBE NEWSWIRE) -- Advanced Rehabilitation, LLC today announced the expansion of its educational platform featuring the integrated Kinetic Neuro-Ortho Training (iKNOT) approach. The digital curriculum...

Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering

2026-06-23T08:00:00Z

JUPITER, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today the pricing of $625.0 million aggregate principal amount of 0.0% convertible senior notes due...

Transactions in connection with share buy-back program

2026-06-23T08:00:00Z

Company announcement no. 22 - 2623 June 2026

CGA.vitaslim Announces Mission to Help 5,000 Adults Combat the "Three Highs" and Reclaim Their Health and Wealth in Hong Kong

2026-06-23T06:54:00Z

HONG KONG, June 23, 2026 (GLOBE NEWSWIRE) -- CGA.vitaslim, a premier health and wellness consultancy, today announced the launch of a new community-focused initiative aimed at helping 5,000 individuals aged...

Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission

2026-06-23T06:30:00Z

ORION CORPORATION PRESS RELEASE 23 JUNE 2026 at 9:30 EEST Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission

BienRaíz Launches Vitamin D3 5000 IU Softgels: A High-Potency, Simple Formula for Everyday Wellness

2026-06-23T05:44:31Z

New Vitamin D3 Supplement Delivers 5000 IU of Cholecalciferol in Easy-to-Take Softgels Designed for Adults Seeking a Flexible Daily Wellness Routine

Nicox and Vester Finance Sign Shareholder Loan Agreement to Support Strategic Activities for the Company

2026-06-23T05:30:00Z

1 Lower of the two daily volume-weighted average prices over the period immediately preceding each issue.2 At least equal to the volume-weighted average of the share prices over the three...

Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia

2026-06-23T05:15:00Z

Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia

argenx to Host Autoimmune Myositis R&D Webinar

2026-06-23T05:00:00Z

June 23, 2026, 7:00 AM CET

Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses

2026-06-23T05:00:00Z

Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses

Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2026-06-23T00:49:59Z

SAN MATEO, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that...

COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment

2026-06-23T00:16:00Z

TORONTO, ONTARIO, June 22, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) announced the next steps in connection with changes to the Company’s...

The Health Institute Announces Heal Your Cells, a New Book by Dr. Josh Axe and Dr. Will Cole on Cellular Health and Healthy Aging

2026-06-22T23:00:00Z

Inspired by personal loss and years of clinical practice, the forthcoming release explores how cellular function may influence energy, wellness, and long-term health.

Transactions of Managers and Closely Associated Persons

2026-06-22T22:48:04Z

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 10,133,333...

Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

2026-06-22T21:40:00Z

MELBOURNE, Australia and INDIANAPOLIS, June 23, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces an educational webinar exploring the unmet needs in neurologic oncology...

Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

2026-06-22T21:30:00Z

TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Thursday,...

Pioneering screening test offers potential to find more aggressive prostate cancers

2026-06-22T21:00:00Z

Annals of Internal Medicine publishes study showing potential benefits of Stockholm3 in identifying patients with aggressive prostate cancer

20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month

2026-06-22T20:45:00Z

Inaugural Session to be Held Wednesday, July 1, 2026, at 12:00 p.m. ET

MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval

2026-06-22T20:43:38Z

ROCKVILLE, MD, June 22, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that...